Chemed Corporation $CHE Shares Sold by GPS Wealth Strategies Group LLC

GPS Wealth Strategies Group LLC cut its holdings in shares of Chemed Corporation (NYSE:CHE) by 69.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 616 shares of the company’s stock after selling 1,401 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Chemed were worth $264,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. WCM Investment Management LLC lifted its holdings in Chemed by 3.8% during the 3rd quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock worth $299,000 after buying an additional 24 shares in the last quarter. Eukles Asset Management lifted its holdings in Chemed by 0.4% during the 3rd quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock worth $2,700,000 after buying an additional 24 shares in the last quarter. Cim LLC lifted its holdings in Chemed by 1.1% during the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after buying an additional 24 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares in the last quarter. Finally, Inscription Capital LLC lifted its holdings in Chemed by 7.5% during the 3rd quarter. Inscription Capital LLC now owns 458 shares of the company’s stock worth $205,000 after buying an additional 32 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Price Performance

Chemed stock opened at $439.70 on Friday. The stock has a market cap of $5.83 billion, a P/E ratio of 23.96, a price-to-earnings-growth ratio of 1.66 and a beta of 0.54. The company has a fifty day simple moving average of $400.27 and a 200-day simple moving average of $425.05. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $581.20. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the company earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts expect that Chemed Corporation will post 22.3 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is 13.08%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Saturday. Oppenheimer dropped their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Royal Bank Of Canada lifted their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $501.50.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 3.33% of the stock is owned by company insiders.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.